FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160168356> ?p ?o ?g. }

• W2160168356 endingPage "831" @default.
• W2160168356 startingPage "825" @default.
• W2160168356 abstract "Purpose There is no consensus on the best regimen for the primary treatment of low-risk gestational trophoblastic neoplasia (GTN). Patients and Methods Two commonly used single-drug regimens were compared with respect to the proportion of patients meeting the criteria for a complete response (CR) in a randomized phase III trial conducted by the Gynecologic Oncology Group. Eligibility was purposefully broad to maximize the generalizability of the results and included patients with a WHO risk score of 0 to 6 and patients with metastatic disease (limited to lung lesions < 2 cm, adnexa, or vagina) or choriocarcinoma. Results Two hundred forty women were enrolled, and 216 were deemed eligible. Biweekly intravenous dactinomycin 1.25 mg/m 2 was statistically superior to weekly intramuscular (IM) methotrexate 30 mg/m 2 (CR: 70% v 53%; P = .01). Similarly, in patients with low-risk GTN as defined before the 2002 WHO risk score revisions (risk score of 0 to 4 and excluding choriocarcinoma), response was 58% and 73% in the methotrexate and dactinomycin arms, respectively (P = .03). Both regimens were less effective if the WHO risk score was 5 or 6 or if the diagnosis was choriocarcinoma (CR: 9% and 42%, respectively). There were two potential recurrences; one at 4 months (dactinomycin) and one at 22 months (methotrexate). Not all patients completed follow-up. Both regimens were well tolerated. Conclusion The biweekly dactinomycin regimen has a higher CR rate than the weekly IM methotrexate regimen in low-risk GTN, a generally curable disease." @default.
• W2160168356 created "2016-06-24" @default.
• W2160168356 creator A5028695126 @default.
• W2160168356 creator A5035033331 @default.
• W2160168356 creator A5037590677 @default.
• W2160168356 creator A5052993364 @default.
• W2160168356 creator A5053329940 @default.
• W2160168356 creator A5061736280 @default.
• W2160168356 creator A5062151371 @default.
• W2160168356 creator A5071539254 @default.
• W2160168356 creator A5084423190 @default.
• W2160168356 creator A5089044340 @default.
• W2160168356 date "2011-03-01" @default.
• W2160168356 modified "2023-10-05" @default.
• W2160168356 title "Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study" @default.
• W2160168356 cites W1523520347 @default.
• W2160168356 cites W1968373373 @default.
• W2160168356 cites W1981256649 @default.
• W2160168356 cites W1995694389 @default.
• W2160168356 cites W2000817015 @default.
• W2160168356 cites W2010443570 @default.
• W2160168356 cites W2031374937 @default.
• W2160168356 cites W2035110215 @default.
• W2160168356 cites W2041876783 @default.
• W2160168356 cites W2042920161 @default.
• W2160168356 cites W2049526287 @default.
• W2160168356 cites W2051200513 @default.
• W2160168356 cites W2052435992 @default.
• W2160168356 cites W2080876162 @default.
• W2160168356 cites W2100548380 @default.
• W2160168356 cites W2148068022 @default.
• W2160168356 cites W95299923 @default.
• W2160168356 doi "https://doi.org/10.1200/jco.2010.30.4386" @default.
• W2160168356 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3068058" @default.
• W2160168356 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21263100" @default.
• W2160168356 hasPublicationYear "2011" @default.
• W2160168356 type Work @default.
• W2160168356 sameAs 2160168356 @default.
• W2160168356 citedByCount "133" @default.
• W2160168356 countsByYear W21601683562012 @default.
• W2160168356 countsByYear W21601683562013 @default.
• W2160168356 countsByYear W21601683562014 @default.
• W2160168356 countsByYear W21601683562015 @default.
• W2160168356 countsByYear W21601683562016 @default.
• W2160168356 countsByYear W21601683562017 @default.
• W2160168356 countsByYear W21601683562018 @default.
• W2160168356 countsByYear W21601683562019 @default.
• W2160168356 countsByYear W21601683562020 @default.
• W2160168356 countsByYear W21601683562021 @default.
• W2160168356 countsByYear W21601683562022 @default.
• W2160168356 countsByYear W21601683562023 @default.
• W2160168356 crossrefType "journal-article" @default.
• W2160168356 hasAuthorship W2160168356A5028695126 @default.
• W2160168356 hasAuthorship W2160168356A5035033331 @default.
• W2160168356 hasAuthorship W2160168356A5037590677 @default.
• W2160168356 hasAuthorship W2160168356A5052993364 @default.
• W2160168356 hasAuthorship W2160168356A5053329940 @default.
• W2160168356 hasAuthorship W2160168356A5061736280 @default.
• W2160168356 hasAuthorship W2160168356A5062151371 @default.
• W2160168356 hasAuthorship W2160168356A5071539254 @default.
• W2160168356 hasAuthorship W2160168356A5084423190 @default.
• W2160168356 hasAuthorship W2160168356A5089044340 @default.
• W2160168356 hasBestOaLocation W21601683561 @default.
• W2160168356 hasConcept C126322002 @default.
• W2160168356 hasConcept C141071460 @default.
• W2160168356 hasConcept C153911025 @default.
• W2160168356 hasConcept C168563851 @default.
• W2160168356 hasConcept C2776694085 @default.
• W2160168356 hasConcept C2776695378 @default.
• W2160168356 hasConcept C2778128677 @default.
• W2160168356 hasConcept C2780435969 @default.
• W2160168356 hasConcept C2780832733 @default.
• W2160168356 hasConcept C2781059491 @default.
• W2160168356 hasConcept C2781413609 @default.
• W2160168356 hasConcept C2909593222 @default.
• W2160168356 hasConcept C3675279 @default.
• W2160168356 hasConcept C71924100 @default.
• W2160168356 hasConcept C86803240 @default.
• W2160168356 hasConceptScore W2160168356C126322002 @default.
• W2160168356 hasConceptScore W2160168356C141071460 @default.
• W2160168356 hasConceptScore W2160168356C153911025 @default.
• W2160168356 hasConceptScore W2160168356C168563851 @default.
• W2160168356 hasConceptScore W2160168356C2776694085 @default.
• W2160168356 hasConceptScore W2160168356C2776695378 @default.
• W2160168356 hasConceptScore W2160168356C2778128677 @default.
• W2160168356 hasConceptScore W2160168356C2780435969 @default.
• W2160168356 hasConceptScore W2160168356C2780832733 @default.
• W2160168356 hasConceptScore W2160168356C2781059491 @default.
• W2160168356 hasConceptScore W2160168356C2781413609 @default.
• W2160168356 hasConceptScore W2160168356C2909593222 @default.
• W2160168356 hasConceptScore W2160168356C3675279 @default.
• W2160168356 hasConceptScore W2160168356C71924100 @default.
• W2160168356 hasConceptScore W2160168356C86803240 @default.
• W2160168356 hasIssue "7" @default.
• W2160168356 hasLocation W21601683561 @default.
• W2160168356 hasLocation W21601683562 @default.
• W2160168356 hasLocation W21601683563 @default.
• W2160168356 hasLocation W21601683564 @default.

• next